Aurora Cannabis (ACB) Current Deferred Revenue (2018 - 2025)

Aurora Cannabis (ACB) has reported Current Deferred Revenue for 8 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.

• Quarterly Current Deferred Revenue fell 38.96% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (down 38.96% YoY) and the FY2025 annual result came in at $772590.5, down 38.29% from the prior year.
• Current Deferred Revenue advanced to $1.4 million in Q4 2025 per ACB's latest filing, from $1.0 million in the prior quarter.
• Over the last five years, Current Deferred Revenue for ACB reached as high as $5.2 million in Q3 2021 and fell as low as $748488.3 in Q1 2025.
• A 5-year average of $2.2 million and a median of $1.8 million in 2022 frame the typical range for Current Deferred Revenue.
• Annual changes were most pronounced in 2021 — Current Deferred Revenue surged 221.14% — and 2023, when it slumped 67.08%.
• Year by year, Current Deferred Revenue stood at $4.4 million in 2021, then plunged by 53.57% to $2.0 million in 2022, then gained by 26.45% to $2.6 million in 2023, then declined by 12.39% to $2.2 million in 2024, then sank by 38.96% to $1.4 million in 2025.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $1.4 million, $1.0 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.